ATSDR's trichloroethylene subregistry methods and results: 1989-2000

Archives of Environmental and Occupational Health

Volumn 60, Issue 3, 2005, Pages 130-139

  Davis, Stephanie I ^a,b   Pallos, L Laszlo ^a   Wu, Jennifer Q ^a   Sapp II, James H ^a   Cusack, Caroline ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

^b Mail Stop E 31 ^*  (United States)

Author keywords

Cohort; Drinking water; Exposure; Registry; TCE Subregistry

Indexed keywords

DRINKING WATER; FRESH WATER; TRICHLOROETHYLENE;

AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; INTERVIEW; MORBIDITY; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; REGISTER; SEX RATIO; STATISTICAL ANALYSIS; UNITED STATES; ADOLESCENT; ADULT; AGED; CHILD; DANGEROUS GOODS; FEMALE; INFANT; MALE; MIDDLE AGED; NEWBORN; POISSON DISTRIBUTION; PRESCHOOL CHILD; WATER POLLUTANT; WATER SUPPLY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FRESH WATER; HAZARDOUS SUBSTANCES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; POISSON DISTRIBUTION; REGISTRIES; SEX DISTRIBUTION; TRICHLOROETHYLENE; UNITED STATES; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 33751176638     PISSN: 19338244     EISSN: None     Source Type: Journal    
DOI: 10.3200/AEOH.60.3.130-139     Document Type: Article

References (43)

1. Agency for Toxic Substances and Disease Registry. National Exposure Registry Trichloroethylene (TCE) Subregistry Baseline Technical Report (Revised). Atlanta, GA: US Department of Health and Human Services; 1994:1-230. NTIS publication PB95-154589.
2. Agency for Toxic Substances and Disease Registry. National Exposure Registry: Policies and Procedures Manual (Revised). Atlanta, GA: US Department of Health and Human Services; 1994:1-44. NTIS publication PB95-154571.
3. Agency for Toxic Substances and Disease Registry. National Exposure Registry Trichloroethylene (TCE) Subregistry Baseline Through Follow-up 3 Technical Report. Atlanta, GA: US Department of Health and Human Services; 1999: 1-292. NTIS publication PB99-168296.
4. US Environmental Protection Agency. National Priorities List Advanced Query. Available at: http://www.epa.gov/superfund/sites/query/advquery.htm. Accessed June 15, 2006.
5. Gist GL, Burg JR, Radke TM. The site selection process for the National Exposure Registry. J Environ Health. 1994; 56:7-12.
6. Agency for Toxic Substances and Disease Registry. Report on the Battle Creek Health Study. Atlanta, GA: US Department of Health and Human Services; 1988:1-263.
7. Adams PF, Marano MA. Current Estimates from the National Health Interview Survey, 1994. Atlanta, GA: US Department of Health and Human Services; 1995. Vital Health Stat 10. 1995; No. 193.
8. International Classification of Diseases, 9th revision. Geneva, Switzerland: World Health Organization; 1977.
9. Griebling TL. Urologic Diseases in America Project: trends in resource use for urinary tract infections in women. J Urol. 2005; 173:1281-1287.
10. Griebling TL. Urologic Diseases in America Project: trends in resource use for urinary tract infections in men. J Urol. 2005; 173:1288-1294.
11. Nomiyama K, Nomiyama H. Metabolism of trichloroethylene in humans. Sex difference in urinary excretion of trichloroacetic acid and trichloroethanol. Int Arch Arbeitsmed. 1971; 28:37-48.
12. Breslow NE, Day NE. Design considerations. In: Heseltine E, ed. Statistical Methods in Cancer Research: Volume II - The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer; 1987:271-314.
13. Baker RJ, Neider JA. Generalized Linear Interactive Modeling [software]. Release 3.77. Oxford, England: Royal Statistical Society; 1978.
14. Burg JR, Gist GL. Health effects of environmental contaminant exposure: an intrafile comparison of the Trichloroethylene Subregistry. Arch Environ Health. 1999; 54:231-241.
15. Tse SY, Mak IT, Weglicki WB, et al. Chlorinated aliphatic hydrocarbons promote lipid peroxidation in vascular cells. J Toxicol Environ Health. 1990; 31:217-226.
16. Goel SK, Rao GS, Pandya KP, et al. Trichloroethylene toxicity in mice: a biochemical, hematological and pathological assessment. Indian J Exp Biol. 1992; 30:402-406.
17. Boyer AS, Finch WT, Runyan RB. Trichloroethylene inhibits development of embryonic heart valve precursors in vitro. Toxicol Sci. 2000; 53:109-117.
18. Ou J, Ou Z, McCarver DG, et al. Trichloroethylene decreases heat shock protein 90 interactions with endothelial nitric oxide synthase: implications for endothelial cell proliferation. Toxicol Sci. 2003; 73:90-97.
19. Parker MJ, Tarlow MJ, Milne AJ. Glue sniffing and cerebral infarction. Arch Dis Child. 1984; 59:675-677.
20. Allemand H, Pessayre D, Descatoire V, et al. Metabolic activation of trichloroethylene into a chemically reactive metabolite toxic to the liver. J Pharmacol Exp Ther. 1978; 204:714-723.
21. Klotz U, Ammon E. Clinical toxicological consequences of the inductive potential of ethanol. Eur J Clin Pharmacol. 1998; 54:7-12.
22. Reif JS, Burch JB, Nuckols JR, et al. Neurobehavioral effects of exposure to trichloroethylene through a municipal water supply. Environ Res. 2003; 93:248-258.
23. Nakajima T, Yamanoshita O, Kamijima M, et al. Generalized skin reactions in relation to trichloroethylene exposure: a review from the viewpoint of drug-metabolizing enzymes. J Occup Health. 2003; 45:8-14.
24. Griffin JM, Gilbert KM, Lamps LW, et al. CD4(+) T-cell activation and induction of autoimmune hepatitis following trichloroethylene treatment in MRL+/+ mice. Toxicol Sci. 2000; 57:345-352.
25. Griffin JM, Gilbert KM, Pumford NR. Inhibition of CYP2E1 reverses CD4+ T-cell alterations in trichloroethylene-treated MRL+/+ mice. Toxicol Sci. 2000; 54:384-389.
26. Iavicoli I, Marinaccio A, Carelli G. Effects of occupational trichloroethylene exposure on cytokine levels in workers. J Occup Environ Med. 2005; 47:453-457.
27. Lockey JE, Kelly CR, Cannon GW, et al. Progressive systemic sclerosis associated with exposure to trichloroethylene. J Occup Med. 1987; 29:493-496.
28. Kilburn KH, Warshaw RH. Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ Res 1992; 57:1-9.
29. Waller PA, Clauw D, Cupps T, et al. Fasciitis (not schleroderma) following prolonged exposure to an organic solvent (trichloroethylene). J Rheumatol. 1994; 21:1567-1570.
30. Garabrant DH, Lacey JV Jr, Laing TJ, et al. Scleroderma and solvent exposure among women. Am J Epidemiol. 2003; 157:493-500.
31. Monge L, Bruno G, Pinach S, et al. A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years. Diabet Med. 2004; 21:456-459.
32. Landin-Olsson M. Latent autoimmune diabetes in adults. Ann NY Acad Sci.2002; 958:112-116.
33. Moser VC, MacPhail RC, Gennings C. Neurobehavioral evaluations of mixtures of trichloroethylene, heptachlor, and di(2-ethylhexyl)phthalate in a full factorial design. Toxicology. 2003; 188:125-137.
34. Valic E, Waldhör T, Konnaris C, et al. Acquired dyschromatopsia in combined exposure to solvents and alcohol. Int Arch Occup Environ Health. 1997; 70:403-406.
35. Rebert CS, Boyes WK, Pryor GT, et al. Combined effects of solvents on the rat's auditory system: styrene and trichloroethylene. Int J Psychophysiol. 1993; 14:49-59.
36. Agency for Toxic Substances and Disease Registry. Impact of Trichloroethylene Exposure on Oral Motor, Speech, and Hearing in Children - Final Report. Atlanta, GA: US Department of Health and Human Services; 2002;1-156. NTIS publication PB2004-100016.
37. Lash LH, Fisher JW, Lipscomb JC, et al. Metabolism of trichloroethylene. Environ Health Perspect. 2000; 108(suppl 2):177-200.
38. Bruning T, Golka K, Makropoulos V, et al. Preexistence of chronic tubular damage in cases of renal cell cancer after long and high exposure to trichloroethylene. Arch Toxicol. 1996; 70(3-4):259-260.
39. Bruning T, Sundberg AG, Birner G, et al. Glutathione transferase alpha as a marker for tubular damage after trichloroethylene exposure. Arch Toxicol. 1999; 73(4-5):246-254.
40. Bolt HM, Lammert M, Selinski S, et al. Urinary alpha1-microglobulin excretion as biomarker of renal toxicity in trichloroethylene-exposed persons. Int Arch Occup Environ Health. 2004; 77:186-190.
41. Raaschou-Nielsen O, Hansen J, McLaughlin JK, et al. Cancer risk among workers at Danish companies using trichloroethylene: a cohort study. Am J Epidemiol. 2003; 158:1182-1192.
42. Graham SE, McCurdy T. Developing meaningful cohorts for human exposure models. J Expo Anal Environ Epidemiol. 2004; 14:23-43.
43. Sato A, Endoh K, Kaneko T, et al. A simulation study of physiological factors affecting pharmacokinetic behavior of organic solvent vapours. Br J Ind Med. 1991; 48:342-347.